source
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and moreSanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with staff over its approvalSTAT · 2mo ago↗ source
- STAT+: FDA revisits a rare cancer treatment it rejected a few months agoSecret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The ReadoutSTAT · 2mo ago↗ source
- STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and moreIn this edition of STAT Health Tech: A health policy blueprint from OpenAI, CGM updates from Dexcom, and push back against whole body scans.STAT · 2mo ago↗ source